Combination therapy of colon carcinoma 26 in mice with recombinant human interleukin-2 and interferon-alpha A/D: occurrence of large granular cells in the tumor
- PMID: 2513305
- PMCID: PMC5917860
- DOI: 10.1111/j.1349-7006.1989.tb01732.x
Combination therapy of colon carcinoma 26 in mice with recombinant human interleukin-2 and interferon-alpha A/D: occurrence of large granular cells in the tumor
Abstract
The antitumor effects of recombinant human interleukin-2 (rIL-2), in combination with recombinant human interferon-alpha A/D hybrid (rIFN-alpha A/D) on colon carcinoma 26 (colon 26) in mice were examined histologically. Colon 26 was transplanted subcutaneously into female BALB/c mice on day 0. The mice bearing the tumor received intramuscular injections of rIL-2, rIFN-alpha A/D or the combination of rIL-2 and rIFN-alpha A/D for 2-10 consecutive days starting on day 7. Mice were killed on days 9, 13, 17 and 21. After day 13, growth of the tumor was significantly suppressed in the mice treated with rIL-2 or rIFN-alpha A/D alone and was stopped in the mice treated with rIL-2 in combination with rIFN-alpha A/D. Histologically, tumor necrosis developed in all treated groups, though the degree was the most severe in the group receiving combination treatment. Many large cells (about 15-30 microns in diameter) infiltrated into the tumor, and they had Thy-1 surface antigen and many periodic acid-Schiff-positive round granules in the cytoplasm. The incidence of these large granular cells was correlated well with the reduction in tumor weight. The ultrastructural features of the large granular cells were very similar to those of murine large granular lymphocyte-like cells maintained in vitro in an IL-2-containing medium. The present large granular cells appear to be a kind of activated lymphoid cells.
Similar articles
-
Antitumor effect of recombinant human interleukin-2 on the growth of murine hemangioendothelioma D14 in nude mice: occurrence of large granular cells in the tumor.Jpn J Cancer Res. 1991 Aug;82(8):950-7. doi: 10.1111/j.1349-7006.1991.tb01926.x. Jpn J Cancer Res. 1991. PMID: 1910031 Free PMC article.
-
In vivo antitumor activity of multiple injections of recombinant interleukin 2, alone and in combination with three different types of recombinant interferon, on various syngeneic murine tumors.Cancer Res. 1988 Jan 15;48(2):260-4. Cancer Res. 1988. PMID: 2446744
-
Changes in lymphocyte subsets following multiple administration of recombinant interleukin-2 plus recombinant interferon-beta or -gamma in tumor-bearing mice.Jpn J Cancer Res. 1989 Jun;80(6):554-61. doi: 10.1111/j.1349-7006.1989.tb01675.x. Jpn J Cancer Res. 1989. PMID: 2527216 Free PMC article.
-
The therapeutic activity in cancer of IL-2 in combination with other cytokines.Cancer Surv. 1989;8(4):875-89. Cancer Surv. 1989. PMID: 2701733 Review.
-
The role of interferon alfa in the treatment of metastatic melanoma.Semin Oncol. 1997 Feb;24(1 Suppl 4):S24-31. Semin Oncol. 1997. PMID: 9122731 Review.
Cited by
-
Antitumor effect of recombinant human interleukin-2 on the growth of murine hemangioendothelioma D14 in nude mice: occurrence of large granular cells in the tumor.Jpn J Cancer Res. 1991 Aug;82(8):950-7. doi: 10.1111/j.1349-7006.1991.tb01926.x. Jpn J Cancer Res. 1991. PMID: 1910031 Free PMC article.
-
Enhanced therapeutic effects of anti-tumour agents against growth and metastasis of colon carcinoma 26 when given in combination with interferon and interleukin-2.Clin Exp Metastasis. 1994 Nov;12(6):368-74. doi: 10.1007/BF01755880. Clin Exp Metastasis. 1994. PMID: 7923989
References
-
- ) Ootsu , K. , Gotoh , K. , Houkan , T. and Kusanagi , T.Studies on the combination therapy of recombinant human interferon α A/D (rIFN‐α A/D) and recombinant human interleukin‐2 (rIL‐2, TGP‐3) in murine tumors . Proc. Jpn. Cancer Assoc, 45th Annu. Meet. , 578 ( 1986. ) ( in Japanese ).
-
- ) Iigo , M. , Sakurai , M. , Tamura , T. , Saijo , N. and Hoshi , A.In vivo antitumor activity of multiple injections of recombinant interleukin 2, alone and in combination with three different types of recombinant interferon, on various syngeneic murine tumors . Cancer Res. , 48 , 260 – 264 ( 1988. ). - PubMed
-
- ) Rehberg , E. , Kelder , B. , Hoal , E. G. and Pestka , S.Specific molecular activities of recombinant and hybrid leukocyte interferons . J. Biol. Chem. , 257 , 11497 – 11502 ( 1982. ). - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous